ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA

被引：7
|
作者：
EGAWA, H [1 ]
BERQUIST, W [1 ]
SO, SK [1 ]
COX, K [1 ]
MENEGAUX, F [1 ]
ESQUIVEL, CO [1 ]
机构：
[1] CALIF PACIFIC MED CTR,DEPT TRANSPLANTAT,SAN FRANCISCO,CA 94115
来源：
TRANSPLANTATION | 1995年 / 59卷 / 05期
关键词：
D O I：
10.1097/00007890-199503150-00028
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：791 / 793
页数：3
相关论文
共 50 条
  • [11] URINARY ENDOTHELIN AND RENAL VASOCONSTRICTION WITH CYCLOSPORINE OR FK506 AFTER LIVER-TRANSPLANTATION
    TEXTOR, SC
    BURNETT, JC
    ROMERO, JC
    CANZANELLO, VJ
    TALER, SJ
    WIESNER, R
    PORAYKO, M
    KROM, R
    GORES, G
    HAY, E
    KIDNEY INTERNATIONAL, 1995, 47 (05) : 1426 - 1433
  • [12] EARLY CELLULAR REJECTION AFTER ORTHOTOPIC LIVER-TRANSPLANTATION CORRELATES WITH LOW HEPATIC TISSUE FK506 AND IS INDEPENDENT OF PLASMA FK506
    SANDBORN, WJ
    LAWSON, GM
    CODY, TJ
    PORAYKO, MK
    HAY, JE
    GORES, GJ
    STEERS, JL
    KROM, RAF
    WIESNER, RH
    GASTROENTEROLOGY, 1993, 104 (04) : A984 - A984
  • [13] EFFECTS OF FK506 AND 15-DEOXYSPERGUALIN IN RAT ORTHOTOPIC LIVER-TRANSPLANTATION
    INAGAKI, K
    FUKUDA, Y
    SUMIMOTO, K
    MATSUNO, K
    ITO, H
    TAKAHASHI, M
    DOHI, K
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1069 - 1071
  • [14] INFECTIOUS COMPLICATIONS OF PEDIATRIC LIVER-TRANSPLANTATION UNDER FK-506
    GREEN, M
    TZAKIS, A
    REYES, J
    NOUR, B
    TODO, S
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3038 - 3039
  • [15] INCIDENCE AND TREATMENT OF REJECTION EPISODES IN PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION UNDER FK506
    JAIN, AB
    FUNG, JJ
    TODO, S
    ALESSIANI, M
    TAKAYA, S
    ABUELMAGD, K
    TZAKIS, A
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (01) : 928 - 930
  • [16] PRIMARY LIVER-TRANSPLANTATION IN US VETERANS UNDER FK506 IMMUNOSUPPRESSION - A PROSPECTIVE TRIAL
    GAYOWSKI, TJP
    MARINO, JR
    DOYLE, HR
    SINGH, N
    TODO, S
    WAGENER, MM
    MIELES, L
    FUNG, JJ
    STARZL, TE
    HEPATOLOGY, 1995, 22 (04) : 1253 - 1253
  • [17] THE ENHANCED IMMUNOSUPPRESSIVE EFFICACY OF NEWLY DEVELOPED LIPOSOMAL FK506 IN CANINE LIVER-TRANSPLANTATION
    KO, S
    NAKAJIMA, Y
    KANEHIRO, H
    HORIKAWA, M
    YOSHIMURA, A
    TAKI, J
    AOMATSU, Y
    KIN, T
    YAGURA, K
    NAKANO, H
    TRANSPLANTATION, 1995, 59 (10) : 1384 - 1388
  • [18] THE OPTIMAL IMMUNOSUPPRESSANT AFTER LIVER-TRANSPLANTATION ACCORDING TO DIAGNOSIS - CYCLOSPORINE-A OR FK506
    MUELLER, AR
    PLATZ, KP
    BLUMHARDT, G
    BECHSTEIN, WO
    STEINMULLER, T
    CHRISTE, W
    HOPF, U
    LOBECK, H
    NEUHAUS, P
    CLINICAL TRANSPLANTATION, 1995, 9 (03) : 176 - 184
  • [19] EVOLUTION OF CARDIOVASCULAR RISK AFTER LIVER-TRANSPLANTATION - COMPARISON OF CYCLOSPORINE-A AND FK506
    CANZANELLO, VJ
    SCHWARTZ, L
    TALER, SJ
    TEXTOR, SC
    WIESNER, RH
    PORAYKO, MK
    KROM, RA
    HEPATOLOGY, 1994, 20 (04) : A123 - A123
  • [20] Immunosuppression Following Pediatric Heart Transplantation: Cyclosporine A vs FK506 111
    Gilbert Z Herzberg
    Mary Courtney
    Bruce D Gelb
    Anthony F Rossi
    Pediatric Research, 1997, 41 (Suppl 4) : 21 - 21
12345